We recap Day 2 of the 2025 BIO CEO and Investor Conference in New York with a look at what we can expect from the new administration and Congress, as well as promising schizophrenia developments. (347 ...

We recap Day 1 of the 2025 BIO CEO and Investor Conference in New York with exciting developments on obesity drugs and AI. (203 words, 1 minute, 0 seconds) How to follow the BIO CEO & Investor ...

WASHINGTON, D.C. (February 5, 2025) – John F. Crowley, President & CEO of the Biotechnology Innovation Organization (BIO), today released the following statement after introduction of the ORPHAN Cures ...

We're at the BIO CEO & Investor Conference in New York – follow our exclusive coverage at Bio.News and on social media with #BIOCEO25. Below, we have the news you need to know today, plus a look back ...

We're back on a Thursday with news about the ORPHAN Cures Act. (2 minutes, 17 seconds. Contains 459 words) ORPHAN Cures Act reintroduced in the House The ORPHAN Cures Act, a bipartisan bill that ...

BIO’s Industry Analysis Team presents Emerging Therapeutic Company trends across five core areas of investment and deal-making: venture capital, initial public offerings (IPOs), follow-on public ...

As the largest global non-profit biotechnology trade association representing startups to Fortune 500 companies, BIO is proud to host a portfolio of partnering conferences that not only unite and ...